Tianan Pharmaceutical Co Stock Return On Equity
| TNPH Stock | USD 0.01 0.00 0.00% |
Tianan Pharmaceutical Co fundamentals help investors to digest information that contributes to Tianan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Tianan Pink Sheet. The fundamental analysis module provides a way to measure Tianan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tianan Pharmaceutical pink sheet.
Tianan |
Tianan Pharmaceutical Co Company Return On Equity Analysis
Tianan Pharmaceutical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Tianan Pharmaceutical Return On Equity | 0.25 |
Most of Tianan Pharmaceutical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tianan Pharmaceutical Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Tianan Pharmaceutical Co has a Return On Equity of 0.2512. This is 101.05% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The return on equity for all United States stocks is 181.03% lower than that of the firm.
Tianan Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tianan Pharmaceutical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Tianan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Tianan Pharmaceutical by comparing valuation metrics of similar companies.Tianan Pharmaceutical is currently under evaluation in return on equity category among its peers.
Tianan Fundamentals
| Return On Equity | 0.25 | |||
| Return On Asset | 0.18 | |||
| Profit Margin | 0.30 % | |||
| Operating Margin | 0.36 % | |||
| Current Valuation | 979.64 K | |||
| Price To Earning | 0.15 X | |||
| Price To Book | 1.20 X | |||
| Price To Sales | 1.62 X | |||
| Revenue | 10.65 M | |||
| Gross Profit | 7.3 M | |||
| EBITDA | 4.31 M | |||
| Net Income | 3.14 M | |||
| Cash And Equivalents | 8.23 M | |||
| Cash Per Share | 0.59 X | |||
| Current Ratio | 14.23 X | |||
| Book Value Per Share | 1.03 X | |||
| Cash Flow From Operations | 2.56 M | |||
| Earnings Per Share | 0.01 X | |||
| Number Of Employees | 16 | |||
| Beta | 0.86 | |||
| Market Capitalization | 17.29 M | |||
| Total Asset | 15.38 M | |||
| Retained Earnings | 4.96 M | |||
| Working Capital | 11.29 M | |||
| Current Asset | 12.14 M | |||
| Current Liabilities | 853 K | |||
| Net Asset | 15.38 M |
About Tianan Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tianan Pharmaceutical Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tianan Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tianan Pharmaceutical Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Tianan Pink Sheet
Tianan Pharmaceutical financial ratios help investors to determine whether Tianan Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Tianan with respect to the benefits of owning Tianan Pharmaceutical security.